ML19325D109
| ML19325D109 | |
| Person / Time | |
|---|---|
| Issue date: | 04/19/1988 |
| From: | Nussbaumer D NRC OFFICE OF GOVERNMENTAL & PUBLIC AFFAIRS (GPA) |
| To: | Cunningham R NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS) |
| Shared Package | |
| ML19325D099 | List: |
| References | |
| RULE-PRM-35-9 NUDOCS 8910190015 | |
| Download: ML19325D109 (1) | |
Text
,
I
- - M.V.
y,e ;
i a
APR 191988 i
l Ref:
SA/ LAB i
MD40RANDUM FOR:
Richard E. Cunningham, Director Division of Industrial and Medical D
Muclear Safety, NM55 m
FROF.:
Donald A. Nussbaumer, Assistant Director
- for State Agreements Program r
State. Local and Inoian Tribe Programs, GPA l
5t9 JECT:
APPROYAL OF NON-IND/NDA RADI0 PHARMACEUTICALS l
We have been asked by the State of California for an interpretation i:
of the authoritations extended to type A broad medical licenses.
l Seecifically, can their Radiation Safety Comittees authorite physicians t: Use non IND or NDA radiopharmaceuticals in human imagin therapy? Can a Radioactive Drug Research Committee (RDRC)g and approve the above mentioned drugs? Are there any special guidas or license r
conditions applicable to this use of radiopharmaceuticals?
May we please hear from you on this matter by May 2, 19887 ec:
N. McElroy, NMS$
1 Distribution:
52 R d Dir R/F i
LABo111ng/
NFSS file (fc) w/ incoming JForcor, RV, w/ incoming J
)
r r
l.I.
.I..[............I...........
W*1 i
/bh : NuPsbaumer :
L..
.....i..........................................................................
tTE 4 8 88'-